New York, January 5, 2026, 11:38 EST — Regular session
- NuScale Power shares rose about 16% in late morning trade as nuclear-linked stocks rallied.
- A U.S. House panel has scheduled a January 7 hearing focused on nuclear licensing and deployment.
- Small-reactor peers Oklo and Nano Nuclear also climbed in the session.
NuScale Power Corp shares rose 16.1% to $18.93 in late morning trading on Monday. The stock ranged from $16.83 to $19.23, with about 36.3 million shares traded.
The jump underscores how quickly traders are repricing small nuclear-reactor names on policy signals early in the year. For companies still years away from meaningful revenue, the prospect of faster approvals can dominate the tape.
That focus sharpened after the House Energy and Commerce Committee said it will hold a January 7 hearing titled “American Energy Dominance: Dawn of the New Nuclear Era,” spotlighting reactor licensing — the federal approval process for building and operating plants — alongside deployment. “This hearing will offer a chance to discuss the current state of our nuclear industry,” Chair Brett Guthrie and Subcommittee Chair Bob Latta said in a statement. House Committee on Energy and Commerce
NuScale Power, based in Oregon, is developing small modular reactors — smaller nuclear units designed to be manufactured in modules and assembled on site. Backers argue the approach could add carbon-free electricity in increments, rather than through single, multi-gigawatt projects.
The move spread across the niche. Oklo shares were up about 14%, and Nano Nuclear Energy rose roughly 13%, while the S&P 500 ETF SPDR S&P 500 (SPY) added about 0.8%.
NuScale has pointed investors to regulatory milestones as it tries to turn its design into signed customer projects. U.S. regulators approved NuScale’s upgraded 77-megawatt reactor design in 2025, and the company previously scrapped its first planned U.S. project in 2023 after costs climbed.
Even after Monday’s rally, the stock remains far below its prior peak. At $18.93, it is still about 67% under a 52-week high of $57.42, and above a 52-week low of $11.08.
But the headline trade cuts both ways. Any mismatch between upbeat policy messaging and the pace of customer commitments, financing and permitting can reverse momentum quickly in a stock that has swung sharply on sentiment.
Traders now turn to Washington for the next catalyst, with the House hearing set for January 7. For company-specific markers beyond that, market calendars tracked by Zacks and MarketBeat point to NuScale’s next earnings report around March 2.
